Latest Breaking News On - சாதானண்த் கவுடா - Page 13 : comparemela.com

Indian gov t waives off import duty on antiviral drug amid COVID-19 spike - World News

2021-04-21 10:06:07 GMT2021-04-21 18:06:07(Beijing Time) Xinhua English NEW DELHI, April 21 (Xinhua) India s federal government Wednesday announced that it has waived off the import duty on Remdesivir, a broad-spectrum antiviral drug, to provide affordable medical care for the COVID-19 patients, officials said. The step is aimed at increasing the supply of the drug and reduce the cost which will benefit the patients. A notification issued by the federal finance ministry said import duty was removed from Remdesivir active pharmaceutical ingredients, injection and specific substances used in the manufacture of Remdesivir. Considering the immediate requirement on the recommendation of the Department of Pharmaceuticals, the Department of Revenue has waived customs duty on Remdesivir and its Active Pharmaceutical Ingredients (API)/Key Starting Material (KSM). This step will further augment domestic availability of Remdesivir injection, Minister of Chemicals and Fertilizers

Dv sadanand gowdaDepartment of pharmaceuticalsNational institution for transforming indiaDepartment of revenueActive pharmaceutical ingredientsKey starting materialSadanand gowdaTransforming indiaட்வ் சாதானண்த் கவுடாதுறை ஆஃப் மருந்துகள்தேசிய நிறுவனம் க்கு மாற்றும் இந்தியாதுறை ஆஃப் வருவாய்செயலில் மருந்து பொருட்கள்விசை தொடங்குகிறது பொருள்சாதானண்த் கவுடாமாற்றும் இந்தியா

Customs duty waive off on Remdesivir will further augment domestic availability: Sadananda Gowda

The Minister had earlier asked the State governments to take strict action against anyone found indulged in black marketing or hoarding of Remdesivir. The government’s decision to waive off customs duty on antiviral drug Remdesivir would help in augmenting the supply of the medicine in the wake of soaring COVID-19 cases in the country, Chemicals and Fertilizers Minister Sadananda Gowda said on Wednesday. The government on Tuesday waived off all customs duty on imported Remdesivir injections and the drug’s active pharmaceutical ingredients (API) in order to boost supplies. There is already a ban on the export of the Remdesivir injection from the country. “Considering the immediate requirement on the recommendation of the Department of Pharmaceuticals, the Department of Revenue has reduced customs duty on #Remdesivir and its API/KSM. This step will further augment domestic availability of Remdesivir injection,” Mr. Gowda said in a tweet.

Mansukhl mandaviyaSadananda gowdaDepartment of pharmaceuticalsDepartment of revenueFertilizers minister sadananda gowdaFertilizers mansukhl mandaviyaCustoms duty waive off on remdesivirSadanand gowdaActive pharmaceutical ingredientsCustoms duty on antiviral drug remdesivirCustoms duty on remdesivirChemicals and fertilisers ministerNational pharmaceutical pricing authorityசதானந்த கவுடாதுறை ஆஃப் மருந்துகள்துறை ஆஃப் வருவாய்

Customs Duty on Remdesivir has been waived off - New Delhi Times - India s Only International Newspaper

Customs Duty on Remdesivir has been waived off - New Delhi Times - India s Only International Newspaper
newdelhitimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newdelhitimes.com Daily Mail and Mail on Sunday newspapers.

Dv sadanand gowdaDepartment of pharmaceuticalsDepartment of revenueUnion ministerSadanand gowdaட்வ் சாதானண்த் கவுடாதுறை ஆஃப் மருந்துகள்துறை ஆஃப் வருவாய்தொழிற்சங்கம் அமைச்சர்சாதானண்த் கவுடா

India afronta crisis de suministros en medio de recórd de contagios por COVID

India afronta crisis de suministros en medio de recórd de contagios por COVID
proceso.hn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proceso.hn Daily Mail and Mail on Sunday newspapers.

Uttar pradeshUnited statesNew delhiSadanand gowdaArvind kejriwalAmericans gilead sciences incInstitute serum of indiaWestern stateMax field hospitalModi narendraMinister forInstitute serumஉத்தர் பிரதேஷ்ஒன்றுபட்டது மாநிலங்களில்புதியது டெல்ஹிசாதானண்த் கவுடா

Remedieswear prices cut on government intervention: industry bodies

Remedieswear prices cut on government intervention: industry bodies 0 0 2 minutes read Pharmaceutical companies have reduced the price of Remedisvir Injection. New Delhi: The National Pharmaceutical Pricing Authority (NPPA) said on Saturday that pharmaceutical companies have lowered the price after government intervention to increase the availability of Remedisvir injections used in the treatment of COVID-19. Pharmaceutical companies such as Cadila Healthcare, Dr. Reddy’s Laboratories and Cipla have cut prices of their brand’s Remedisavir Injection (100 mg / vial). The antiviral drug is used in the treatment of COVID-19. Union Chemicals and Fertilizers Minister Sadanand Gowda praised the decision taken by the pharmaceutical companies.

New delhiMansukhl mandaviaSadanand gowdaNational pharmaceutical pricing authorityUnion chemicalsSyngene internationalCenter onCadila healthcareRemedisavir injectionFertilizers minister sadanand gowdaFertilizers mansukhJubilant genericNawab malikபுதியது டெல்ஹிசாதானண்த் கவுடாதேசிய மருந்து ப்ரைஸிஂக் அதிகாரம்